MedTrace Logo

A Group-Based Walking Study Using WeChat to Enhance Physical Activity Among Older Adults

NCT03803085 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-11-09

Study results available
· View outcomes & findings →

Summary

The aim for the study is to use the function WeRun in the application WeChat to encourage physical activity and social engagement among community dwelling older adults and their family members and friends. The specific aims are to test the effectiveness of a social contact and comparison intervention for increasing regular daily physical activity among community dwelling older adults, and to examine the potential effectiveness of WeChat in cultivating social engagement and well-being among community dwelling older adults.

Conditions

  • Inactivity
  • Sedentary Behavior

Interventions

BEHAVIORAL

Control condition

Participants in the control group only saw their own daily walking steps using the WeChat. They did not use WeChat to see other group members' daily steps and did not contact other group members. The participants were asked to use the app every day. A message (through WeChat) was sent to remind them to use the application if they had not done so within three days.

BEHAVIORAL

Treatment condition

Participants in the experimental condition used WeChat for 4 weeks to see their own and other's walking steps and also were able to contact other group members. The participants were asked to use the application every day. A message (through the group chat) was sent to remind them to use the application if they have not done so within three days.

Sponsors & Collaborators

  • Brandeis University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2019-06-01
Completion
2019-07-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03803085 on ClinicalTrials.gov